These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14999149)

  • 1. RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells.
    Wu M; Wu ZF; Kumar-Sinha C; Chinnaiyan A; Merajver SD
    Breast Cancer Res Treat; 2004 Mar; 84(1):3-12. PubMed ID: 14999149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
    van Golen KL; Wu ZF; Qiao XT; Bao LW; Merajver SD
    Cancer Res; 2000 Oct; 60(20):5832-8. PubMed ID: 11059780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.
    van Golen KL; Wu ZF; Qiao XT; Bao L; Merajver SD
    Neoplasia; 2000; 2(5):418-25. PubMed ID: 11191108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
    Wang L; Yang L; Luo Y; Zheng Y
    J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.
    van Golen KL; Bao LW; Pan Q; Miller FR; Wu ZF; Merajver SD
    Clin Exp Metastasis; 2002; 19(4):301-11. PubMed ID: 12090470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis.
    Li DQ; Hou YF; Wu J; Chen Y; Lu JS; Di GH; Ou ZL; Shen ZZ; Ding J; Shao ZM
    Eur J Cancer; 2006 Dec; 42(18):3274-86. PubMed ID: 16979889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
    Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
    Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.
    van Golen KL; Bao L; DiVito MM; Wu Z; Prendergast GC; Merajver SD
    Mol Cancer Ther; 2002 Jun; 1(8):575-83. PubMed ID: 12479217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers.
    Wu M; Wu ZF; Rosenthal DT; Rhee EM; Merajver SD
    Cancer; 2010 Jun; 116(11 Suppl):2768-82. PubMed ID: 20503409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells.
    Chen J; Miller EM; Gallo KA
    Oncogene; 2010 Aug; 29(31):4399-411. PubMed ID: 20514022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.
    Kleer CG; Zhang Y; Pan Q; Gallagher G; Wu M; Wu ZF; Merajver SD
    Breast Cancer Res; 2004; 6(1):R110-5. PubMed ID: 14696649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.
    Van Laere SJ; Van der Auwera I; Van den Eynden GG; Elst HJ; Weyler J; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3249-56. PubMed ID: 16740744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase.
    Joglekar M; Elbezanti WO; Weitzman MD; Lehman HL; van Golen KL
    J Cell Biochem; 2015 Jun; 116(6):923-33. PubMed ID: 25559359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.
    Kleer CG; Griffith KA; Sabel MS; Gallagher G; van Golen KL; Wu ZF; Merajver SD
    Breast Cancer Res Treat; 2005 Sep; 93(2):101-10. PubMed ID: 16187229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of RhoC in growth and metastatic capacity of melanoma.
    Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
    J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
    Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
    Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
    Faried A; Faried LS; Kimura H; Nakajima M; Sohda M; Miyazaki T; Kato H; Usman N; Kuwano H
    Eur J Cancer; 2006 Jul; 42(10):1455-65. PubMed ID: 16750623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into the 6-thiopurine-mediated termination of the invasive motility of tumor cells derived from inflammatory breast cancer.
    Heo J; Wey M; Hong I
    Biochemistry; 2011 Jun; 50(25):5731-42. PubMed ID: 21568348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.